Bio-Rad Introduces Assays that Measure Neutralizing Antibodies Against SARS-CoV-2
The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus.
Read MorePosted by Andy Lundin | Dec 21, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The assays allow scientists to measure neutralizing antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus.
Read MorePosted by Andy Lundin | Dec 21, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The solution aims to make it easier for employers to deploy organizational COVID-19 testing programs in order to avoid penalties from OSHA.
Read MorePosted by Andy Lundin | Dec 21, 2021 | Covid 19, Rapid Assays, Sexually Transmitted Diseases |
The FDA alerted that false reactivity Rapid Plasma Reagin test results in a Bio-Rad RPR kit can occur for some who received a COVID-19 vaccine.
Read MorePosted by Andy Lundin | Dec 20, 2021 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
Applied BioCode has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its BioCode CoV-2 Flu Plus Assay.
Read MorePosted by Andy Lundin | Dec 17, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Early batches of COVID-19 tests from the CDC exhibited false positive reactivity of negative controls due to flaws in the design and components of assays.
Read More